GermanOncology GmbH utilizes its extensive real-world database to assist physicians in devising effective treatment plans for patients through its analysis, consulting, project management, and IT development services.

GermanOncology has created a vast database of more than 26,000 patient files, leaning on its growing network of more than 80 oncologists from around 35 practices across Germany

—Dr Rainer Lipp, MD, Co-Founder and CEO

A&M STABTEST— a specialist in the pharmaceutical analysis of small molecules and biomolecules— offers bioanalytical services solely for the pharmaceutical industry.

The money generated is continually invested in modern analytical equipment and technologies to remain central Europe’s largest provider in the field of pharmaceutical analysis

Dr. Steven A. Watt, Head of Business Development

Synexa provides clients with a broad spectrum of analytical and advising services, including biomarker and bioanalytical readout identification, development, validation, analysis, and interpretation in translational and clinical research. Synexa was established in 2003 as a forerunner in the field of biomarker science.

The company takes pride in developing, executing, and integrating the most effective analytical and data insight approaches to help advance scientific understanding

—Emile Lens, Chief Executive Officer

Artialis is specialized in the development and clinical application of biomarkers-based immunoassays. Since 2021, Artialis is a niche Contract Research and Development Organization (#CRDO) company offering #preclinical, #clinical and #biotesting services. The company offers customized solutions and supports from preclinical (cell culture models and animal studies) to post-marketing clinical phase and a large panel of clinical, imaging and biochemical markers useful to support drug development

Cerba Research provides the highest quality specialized laboratory and diagnostic solutions while leveraging patient data and scientific insight to shape and advance clinical trials. With their global access to leading regional labs, data, patients, technology, and partnered resources, they support global biotech, pharma, and IVD organizations to improve the lives of patients around the world

As an established independent CDMO in the vaccine industry, Intravacc offers a wide range of expertise and is the bridge between your discovery and the start of your phase I/II clinical trials in humans. They at Intravacc are fully aware of the challenges on the long road of vaccine development. We substantially reduce the risks and costs involved with developing vaccines by bridging the gap between your concept and late stage clinical studies

The Kymos Group is an analytical CRO with three European laboratories devoted to providing bioanalytical and CMC services for the life science industry throughout the entire product life cycle: from early research and development to manufacturing and comercialization

MedPharm is a world-leading contract provider of topical and transdermal product design and development services. Their delivery of robust and innovative research has commanded recognition from regulators and investors alike. They utilise their unique cost-effective performance testing models to mitigate risk and accelerate development times

Molecular Devices is one of the world’s leading providers of high-performance life science technology. They make advanced scientific discovery possible for academia, pharma, and biotech customers with platforms for high throughput screening, genomic and cellular analysis, colony selection and microplate detection

The Nuvisan group is a Contract Research Organization (CRO) and Contract Manufacturing Organization (CDMO). Nuvisan offers integrated and coupled services and solutions along the drug development value chain from target identification to the patient with all supporting services (DMPK, GMP synthesis, formulation development and analysis, bioanalysis, Phase 1 CPU, clinical trial supplies and monitoring)